Glenmark Pharma receives USFDA approval for Fluocinolone Acetonide Oil

Glenmark Pharmaceuticals has received final USFDA approval for Fluocinolone Acetonide Oil which is used to treat eczema of the ear. The drug is a generic version of DermOtic Oil, 0.01 per cent of Hill Dermaceuticals, Inc.

According to market estimates, the drug sales data for the 12 month period ending October 2018, is approximately around USD 18.1 million.

Company Profile : Glenmark Pharma Ltd

Be the first to comment

Leave a Reply

Your email address will not be published.


*